Gossamer Bio (NASDAQ: GOSS) shares rallied sharply on Monday after the clinical-stage biotech company said the U.S. Food and Drug
2 hours ago
Shares of Capricor Therapeutics (NASDAQ: CAPR) plunged about 65% on July 27 after FDA briefing documents raised fresh doubts about
3 hours ago
Shares of Hims & Hers Health (NYSE: HIMS) extended their momentum Thursday, climbing about 11% in premarket trading after a
3 months ago
Cocrystal Pharma (NASDAQ: COCP) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its
4 months ago
Cyclerion Therapeutics (NASDAQ: CYCN) saw its stock skyrocket on Wednesday, surging more than 300% during regular trading before extending gains
GlucoTrack (NASDAQ: GCTK) has outlined plans to pursue U.S. regulatory clearance for its glucose monitoring device, a development that quickly
iTonic Holdings (NASDAQ: ITOC) announced a $20 million private placement deal on Monday, sparking a sharp rally in after-hours trading—even
Scienture Holdings (NASDAQ: SCNX) has secured several group purchasing organization (GPO) agreements that significantly expand institutional access to its overdose
5 months ago
ImmunityBio (NASDAQ: IBRX) unveiled a new international partnership designed to expand global access to its cancer therapy, Anktiva. Specifically, the
Shares of Hims & Hers Health (NYSE: HIMS) plunged nearly 10% in regular trading on Tuesday as investors digested a
6 months ago
Novo Nordisk (NYSE: NVO) said it plans to pursue legal and regulatory action against telehealth provider Hims & Hers Health
UnitedHealth Group shares (NYSE: UNH) plunged after U.S. regulators signaled minimal growth in future Medicare Advantage payments, overshadowing the company’s
